RESUMEN
BACKGROUND: Post-inflammatory hyperpigmentation (PIH) is a common occurrence in patients with acne vulgaris, particularly in those with skin of colour. AIMS: A previous study has demonstrated the benefit of tretinoin (retinoic acid) in the treatment of PIH; however, there is currently no standard protocol to evaluate change in PIH following treatment. Based on these findings, we performed a pilot, exploratory, blinded, intraindividual-controlled methodology study that consisted of a photographic assessment protocol with facial mapping. MATERIALS AND METHODS: The study was based on a secondary analysis of a phase 4, community-based trial of 544 acne patients who were treated with tretinoin gel microsphere 0.04% or 0.1%. Only patients with Fitzpatrick types III-V (skin of colour) were included in the study; subjects with Fitzpatrick skin type VI were excluded because the photographic assessment did not allow for proper evaluation. RESULTS: Despite the small number of subjects evaluated (n=25), the results revealed consistent assessment of improvement in PIH between two independent graders (weighted κ=0.84). CONCLUSION: Further study with a larger population is recommended to validate the accuracy of this method.
Asunto(s)
Acné Vulgar/tratamiento farmacológico , Dermatitis/complicaciones , Fármacos Dermatológicos/uso terapéutico , Trastornos de la Pigmentación/patología , Tretinoina/uso terapéutico , Acné Vulgar/complicaciones , Fármacos Dermatológicos/efectos adversos , Humanos , Fotograbar , Trastornos de la Pigmentación/inducido químicamente , Trastornos de la Pigmentación/complicaciones , Proyectos Piloto , Tretinoina/efectos adversosRESUMEN
A randomized study of polymyxin B sulfate-bacitracin zinc-neomycin sulfate versus simple gauze-type dressings in dermabrasion wounds assessed the effects that each treatment had on scarring. Each of three uniform dermabrasion wounds created on the upper backs of 70 subjects was treated concurrently with a triple-antibiotic ointment (polymyxin B-bacitracin-neomycin), a double antibiotic (polymyxin B-bacitracin), or a simple, non-occlusive, gauze-type dressing, twice daily for up to 14 days. Pigmentary changes and textural changes (scarring) appearing after healing at the skin surface test sites were compared to adjacent normal skin at 45 and 90 days post-dermabrasion. These changes were graded visually utilizing fluorescent light, long-wave ultraviolet light, and by clinical color photography. The triple-antibiotic ointment was superior to simple gauze-type dressing alone in minimizing the scarring observed in dermabrasion wounds. The benefit of this new ointment was more pronounced in its effect on pigmentary changes.
Asunto(s)
Cicatriz/prevención & control , Quimioterapia Combinada/administración & dosificación , Piel/lesiones , Cicatrización de Heridas , Administración Cutánea , Adulto , Bacitracina/administración & dosificación , Dermabrasión , Femenino , Humanos , Hiperpigmentación/prevención & control , Masculino , Neomicina/administración & dosificación , Pomadas , Polimixina B/administración & dosificación , Valores de Referencia , Método Simple CiegoAsunto(s)
Trasplante de Corazón/inmunología , Enfermedad de Hodgkin/inmunología , Huésped Inmunocomprometido , Leucemia-Linfoma de Células T del Adulto/inmunología , Tiña/inmunología , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Enfermedad de Hodgkin/terapia , Humanos , Terapia de Inmunosupresión/efectos adversos , Leucemia-Linfoma de Células T del Adulto/terapia , Masculino , Persona de Mediana Edad , Radioterapia AdyuvanteRESUMEN
Optimal topical therapy for distal subungual onychomycosis is not available. An open-label study was performed to determine the safety and efficacy of naftifine hydrochloride (Naftin) 1 percent gel in patients with this disorder of the fingers. Ten patients with culture-proven distal subungual onychomycosis were treated twice daily for six months with naftifine hydrochloride 1 percent gel. At monthly intervals, the target nail was trimmed, the nail bed debrided, and global clinical assessment recorded. Following months three, six, and eight (two months after treatment), the target nail underwent evaluation with potassium hydroxide wet mount and fungal culture. After six months of therapy, eight of ten patients showed negative results of fungal culture and eight of ten patients showed clinical improvement. Adverse effects were minimal and included mild peeling in two patients and mild fissuring with transient fingertip numbness in one patient.
Asunto(s)
Alilamina/análogos & derivados , Antifúngicos/administración & dosificación , Onicomicosis/tratamiento farmacológico , Administración Tópica , Adolescente , Adulto , Anciano , Alilamina/administración & dosificación , Geles , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Onychomycosis is the most frequent cause of nail diseases. An open-label study has been conducted to evaluate the safety and efficacy of Fungoid Tincture, a topical antifungal agent approved by the Food and Drug Administration for the treatment of onychomycosis of the toes. Ten patients with culture-proven distal subungual onychomycosis were treated twice daily for twelve months with topical Fungoid Tincture. Another ten patients with the same condition were treated with the vehicle alone. At monthly intervals, the target nail was trimmed, the nail bed debrided, and global clinical assessment recorded. After twelve months of therapy, all patients applying Fungoid Tincture showed negative findings on fungal culture. The vehicle alone benefitted several patients, and may have antifungal activity. Adverse effects were minimal, with mild peeling occurring in seven patients and erythema noted in one.
Asunto(s)
Antifúngicos/uso terapéutico , Compuestos de Benzalconio/uso terapéutico , Cetilpiridinio/análogos & derivados , Onicomicosis/tratamiento farmacológico , Propionatos/uso terapéutico , Triacetina/uso terapéutico , Xilenos/uso terapéutico , Antifúngicos/administración & dosificación , Compuestos de Benzalconio/administración & dosificación , Cetilpiridinio/administración & dosificación , Cetilpiridinio/uso terapéutico , Combinación de Medicamentos , Femenino , Dermatosis del Pie/tratamiento farmacológico , Humanos , Masculino , Propionatos/administración & dosificación , Triacetina/administración & dosificación , Xilenos/administración & dosificaciónRESUMEN
In this article, we have discussed the possible causes of a longitudinal pigmented nail band. A thorough history, physical examination, and, when indicated, biopsy of the origin of the band should reassure the patient with a benign lesion and direct further treatment of a patient with a malignant or potentially malignant lesion.
Asunto(s)
Enfermedades de la Uña/patología , Trastornos de la Pigmentación/patología , Humanos , Melanocitos/patología , Enfermedades de la Uña/diagnóstico , Enfermedades de la Uña/etiología , Uñas/patología , Trastornos de la Pigmentación/diagnóstico , Trastornos de la Pigmentación/etiología , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/patologíaRESUMEN
The spectrum of nail abnormalities that may be seen in the pediatric population is discussed in this article. Developmental abnormalities, both hereditary and congenital, are discussed. Acquired nail abnormalities that may be similar to those seen in adults are also described.
Asunto(s)
Enfermedades de la Uña , Uñas Malformadas , Adolescente , Infecciones Bacterianas/complicaciones , Niño , Humanos , Micosis/complicaciones , Enfermedades de la Uña/etiología , Uñas/lesionesRESUMEN
Congenital malalignment of the great toenails is a disorder in which malalignment of the nail matrix results in angular lateral nail plate growth. The consequence is onychodystrophy, which may progress to onychogryphosis and chronic ingrown toenails. There has been debate as to whether the condition is inherited or acquired in utero secondary to improper fetal positioning. A 6-year-old boy and his father, both of whom have this disorder, are discussed.